• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[盆腔脏器清除术、发病率及生存率]

[Pelvic exenteration, morbidity and survival].

作者信息

Méndez L, Bernal A, Escudero P, González G, Fajardo A

机构信息

Servicio de Ginecología Oncológica, Hospital Luis Castelazo Ayala, México, D.F.

出版信息

Ginecol Obstet Mex. 1994 Jun;62:161-5.

PMID:8056362
Abstract

Between 1985 and 1990, 17 patients have undergone pelvic exenteration at the Obstetric and Gynecology Hospital 4, Mexican Social Security Institute, Mexico City. Sixteen patients had undergone radiation therapy previously. Most operative procedures were performed for cancer of the cervix, recurrent or persistent. The major type of pelvic neoplasm was epidermoid carcinoma, occurring in 15 patients. No exenterations were performed in presence of pelvic lymph nodes. Operative mortality was 5.8%. One or more major surgical complications occurred in nine patients, three patients required one or more surgical procedures to correct these complications. There was no mortality in patients undergoing reoperation. Nonsurgical complications were encountered in five patients. All patients were followed for at least 2 years or until time of death. The cumulative 5-year survival was significantly related to type of tumor. All patients with recurrent tumor were alive and disease free in the last follow-up compared to only 33% of patients with persistent tumor. Four patients underwent anterior surgical procedure, all with persistent tumour. Three had documented recurrence and none survived beyond 14 months.

摘要

1985年至1990年间,墨西哥社会保障局墨西哥城第四妇产科医院有17例患者接受了盆腔脏器清除术。16例患者此前接受过放射治疗。大多数手术是针对复发性或持续性宫颈癌进行的。盆腔肿瘤的主要类型是表皮样癌,有15例患者。存在盆腔淋巴结时不进行脏器清除术。手术死亡率为5.8%。9例患者发生了一种或多种严重手术并发症,3例患者需要进行一次或多次手术来纠正这些并发症。再次手术的患者无死亡病例。5例患者出现非手术并发症。所有患者均随访至少2年或直至死亡。累积5年生存率与肿瘤类型显著相关。与仅有33%的持续性肿瘤患者相比,所有复发性肿瘤患者在最后一次随访时均存活且无疾病。4例患者接受了前路手术,均为持续性肿瘤。3例有复发记录,无一例存活超过14个月。

相似文献

1
[Pelvic exenteration, morbidity and survival].[盆腔脏器清除术、发病率及生存率]
Ginecol Obstet Mex. 1994 Jun;62:161-5.
2
Indications for primary and secondary exenterations in patients with cervical cancer.宫颈癌患者原发和继发眼眶内容剜除术的适应症。
Gynecol Oncol. 2006 Dec;103(3):1023-30. doi: 10.1016/j.ygyno.2006.06.027. Epub 2006 Aug 4.
3
Pelvic exenteration, University of Michigan: 100 patients at 5 years.密歇根大学盆腔脏器清除术:100例患者的5年随访情况
Obstet Gynecol. 1989 Dec;74(6):934-43.
4
Pelvic exenteration for adenocarcinoma of the uterine cervix.子宫颈腺癌的盆腔脏器切除术
Gynecol Oncol. 1995 Jul;58(1):74-8. doi: 10.1006/gyno.1995.1186.
5
Pelvic exenteration. Has it a role in 1987? A six year experience.盆腔脏器清除术。它在1987年是否有作用?六年的经验。
Verh K Acad Geneeskd Belg. 1989;51(1):31-44; discussion 44-6.
6
Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.伴有不良预后因素的IB-IIB期宫颈癌的术后放射治疗。
Anticancer Res. 2000 May-Jun;20(3B):2235-9.
7
Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.晚期妇科恶性肿瘤患者盆腔廓清术的长期临床结局。
J Surg Oncol. 2010 May 1;101(6):507-12. doi: 10.1002/jso.21518.
8
Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.复发性妇科肿瘤侵犯盆腔壁的手术联合放射治疗五年经验
Cancer. 1996 May 1;77(9):1918-33. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1918::AID-CNCR24>3.0.CO;2-1.
9
Major morbidity after pelvic exenteration: a seven-year experience.盆腔脏器切除术的主要并发症:七年经验总结。
Obstet Gynecol. 1987 Apr;69(4):617-21.
10
[Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].[盆腔脏器清除术——33例临床病例显示的适应证、根治性及随访情况]
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1096-7.